ArticleInternational ophthalmology2020

Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.

Irini Chatziralli et al.PubMed ↗Publisher ↗

No numbers read from the abstract.